These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20150554)

  • 21. Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects.
    Jujić A; Korduner J; Holm H; Engström G; Bachus E; Bhattacharya P; Nilsson PM; Frostegård J; Magnusson M
    Sci Rep; 2021 Oct; 11(1):20246. PubMed ID: 34642415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
    Frostegård J
    Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.
    Elkan AC; Håkansson N; Frostegård J; Cederholm T; Hafström I
    Arthritis Res Ther; 2009; 11(2):R37. PubMed ID: 19284557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.
    Ajeganova S; Andersson MLE; Frostegård J; Hafström I
    Arthritis Res Ther; 2021 Jul; 23(1):201. PubMed ID: 34311770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion.
    Padilla ND; Ciurana C; van Oers J; Ogilvie AC; Hack CE
    J Immunol Methods; 2004 Oct; 293(1-2):1-11. PubMed ID: 15541272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease.
    Silajdžić E; Björkqvist M; Hansson O
    BMC Neurol; 2015 Feb; 15():8. PubMed ID: 25651913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
    Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
    Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia.
    Chen X; Gustafsson S; Whitington T; Borné Y; Lorentzen E; Sun J; Almgren P; Su J; Karlsson R; Song J; Lu Y; Zhan Y; Hägg S; Svensson P; Smedby KE; Slager SL; Ingelsson E; Lindgren CM; Morris AP; Melander O; Karlsson T; de Faire U; Caidahl K; Engström G; Lind L; Karlsson MCI; Pedersen NL; Frostegård J; Magnusson PKE
    Hum Mol Genet; 2018 May; 27(10):1809-1818. PubMed ID: 29547969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
    Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? Comparisons of 15 populations in 9 countries within the WHO MONICA Stroke Project. World Health Organization Monitoring of Trends and Determinants in Cardiovascular Disease.
    Tolonen H; Mähönen M; Asplund K; Rastenyte D; Kuulasmaa K; Vanuzzo D; Tuomilehto J
    Stroke; 2002 Oct; 33(10):2367-75. PubMed ID: 12364723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes.
    Caidahl K; Hartford M; Karlsson T; Herlitz J; Pettersson K; de Faire U; Frostegård J
    Int J Cardiol; 2013 Jul; 167(2):464-9. PubMed ID: 22305633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions.
    Samal SK; Panda PK; Vikström M; Leander K; de Faire U; Ahuja R; Frostegård J
    Front Cardiovasc Med; 2022; 9():809007. PubMed ID: 35479288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential natural immunization against atherosclerosis in hibernating bears.
    Samal SK; Fröbert O; Kindberg J; Stenvinkel P; Frostegård J
    Sci Rep; 2021 Jun; 11(1):12120. PubMed ID: 34108551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against Phosphorylcholine and Malondialdehyde during the First Two Years of Life.
    Thiagarajan D; Lundström SL; Pershagen G; Almqvist C; Andolf E; Hedman A; Berg O; Oparina N; Frostegård J
    J Immunol; 2020 Oct; 205(8):2109-2116. PubMed ID: 32887753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response.
    Diepenhorst GM; Ciurana CL; Diaz Padilla N; Boekholdt SM; Krijnen PA; Lagrand WK; Niessen HW; Hack CE
    Adv Clin Exp Med; 2012; 21(4):455-67. PubMed ID: 23240451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
    Samal SK; Qureshi AR; Rahman M; Stenvinkel P; Frostegård J
    Clin Exp Immunol; 2020 Jul; 201(1):94-104. PubMed ID: 32297318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylcholine antibodies are diminished in ANCA-associated vasculitis.
    Wilde B; Slot M; van Paassen P; Theunissen R; Kemna M; Witzke O; Cohen Tervaert JW
    Eur J Clin Invest; 2015 Jul; 45(7):686-91. PubMed ID: 25940757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylcholine-targeting immunization reduces atherosclerosis.
    Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
    J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
    Rubini Gimenez M; Pagano S; Virzi J; Montecucco F; Twerenbold R; Reichlin T; Wildi K; Grueter D; Jaeger C; Haaf P; Vuilleumier N; Mueller C
    Eur J Clin Invest; 2015 Apr; 45(4):369-79. PubMed ID: 25627775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.